Reinforced biologic material

US9421306B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9421306-B2
Application numberUS-201213616556-A
CountryUS
Kind codeB2
Filing dateSep 14, 2012
Priority dateNov 21, 2008
Publication dateAug 23, 2016
Grant dateAug 23, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides an implantable medical device comprising a composite graft material including a first biologic component, such as an acellular tissue matrix, and a second non-biologic component.

First claim

Opening claim text (preview).

What is claimed is: 1. An implantable medical device, comprising: a plurality of first elongate non-biologic elements, at least a portion of which are under a tensile or compressive stress prior to implantation; at least one biologic component comprising a biomatrix surrounding at least a portion of the plurality of first elongate non-biologic elements; and at least one second elongate non-biologic element, wherein the at least one second element secures at least one end portion of the plurality of first elongate non-biologic elements; wherein the plurality of first elongate non-biologic elements have a higher load capacity than the at least one biologic component at the time of implantation; and wherein the at least one biologic component has a higher load capacity than the plurality of first elongate non-biologic elements after implantation and following growth of native cells within the biomatrix. 2. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements comprises at least one material chosen from bioabsorbable polymer, bioabsorbable metal, or a combination of bioabsorbable polymer and bioabsorbable metal. 3. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements comprise at least one material chosen from polyhydroxyalkanoate, poly-hydroxybutyrate, polylactic acid (PLA), polyglycolic acid (PGA), polylactideglycolide acid (PLGA), polydioxanone (PDO), polycaprolactone (PCL), a polyanhydride, a polyorthoester, a poly(amino acid), a polypeptide, a polydepsipeptide, a nylon-2/nylon-6 copolyamide, a poly(alkylene succinate), poly(hydroxyl butyrate) (PHB), poly(butylene diglocolate), poly(.epsilon.-caprolactone), a polydihydropyran, a polyphosphazene, a poly(cyano acrylates), modified polysaccharides, cellulose, starch, chitin, modified proteins, collagen, fibrin, and combinations and copolymers thereof. 4. The implantable medical device of claim 1 , wherein the biomatrix comprises an acellular tissue matrix or a particulate acellular tissue matrix. 5. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements comprises a bioabsorbable polymer, a bioabsorbable metal or a combination of a bioabsorbable polymer and bioabsorbable metal. 6. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements are under a tensile stress ranging from greater than 0 N to about 1800 N. 7. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements comprises a plurality of threads, cords, cables, ribbons, or braids. 8. The implantable medical device of claim 1 , wherein the at least one biologic component at least partially separates the elongate first elements comprised within the plurality of elongate first non-biologic elements. 9. The implantable medical device of claim 1 , wherein the at least one biologic component at least partially coats each element comprised within the plurality of first elongate non-biologic elements. 10. The implantable medical device of claim 1 , wherein the at least one biologic component is in the form of a coating, a paste, a powder, or a liquid. 11. The implantable medical device of claim 1 , wherein the at least one second elongate non-biologic element secures at least one end of the plurality of first elongate non-biologic elements by at least one of whipping, wrapping, and winding. 12. The implantable medical device of claim 1 , wherein the at least one second elongate non-biologic element comprises the same material as the plurality of first elongate non-biologic elements. 13. The implantable medical device of claim 1 , wherein at least a portion of the plurality of first elongate non-biologic elements are under a longitudinal tensile or compressive stress prior to implantation. 14. The implantable medical device of claim 1 , wherein at least a portion of the plurality of first elongate non-biologic elements are under a tensile or compressive stress of at least about 0.1 N prior to implantation. 15. The implantable medical device of claim 1 , wherein at least a portion of the plurality of first elongate non-biologic elements are under a tensile or compressive stress ranging from about 0.1 N to about 1800 N prior to implantation. 16. An implantable medical device, comprising: a plurality of first elongate non-biologic elements, at least a portion of which are under a tensile or compressive stress prior to implantation; at least one biologic component comprising a biomatrix surrounding at least a portion of the plurality of first elongate non-biologic elements; and at least one second elongate non-biologic element, wherein the at least one second element secures at least one end portion of the plurality of first elongate non-biologic elements; wherein the plurality of first elongate non-biologic elements have a higher load capacity than the at least one biologic component at the time of implantation; wherein the at least one biologic component has a higher load capacity than the plurality of first elongate non-biologic elements after implantation and following growth of native cells within the biomatrix; and wherein the at least one second elongate non-biologic element forms a screw-thread pattern compatible with threads of an anchoring screw.

Assignees

Inventors

Classifications

  • A61L27/48Primary

    with macromolecular fillers · CPC title

  • Artificial members, protheses · CPC title

  • for reconstruction of tendons or ligaments · CPC title

  • A61L27/44Primary

    having a macromolecular matrix · CPC title

  • around tubular articles · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9421306B2 cover?
The present disclosure provides an implantable medical device comprising a composite graft material including a first biologic component, such as an acellular tissue matrix, and a second non-biologic component.
Who is the assignee on this patent?
Park Jason, Barere Aaron, Wagner Christopher T, and 3 more
What technology area does this patent fall under?
Primary CPC classification A61L27/48. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).